rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

James P. Panek

Director

Company insider

Files Form 4 as: Director, Sutro Biopharma; Chief Executive Officer, diaDexus.

Every Form 4 they filed

In numbers

Trades disclosed
28
Buys
1
Sells
0
Bought
$6,000
Sold
$0
Companies
2
Companies where not an officer
1
First trade
12 Feb 2007
Last trade
5 Jun 2026
Last filed
9 Jun 2026

Companies traded

Where they are an officer
diaDexusDirector, Officer · last 29 May 20141 buy · 0 sells
Everywhere else they filed: board seats, 10% stakes, other companies
STRO Sutro BiopharmaDirector · Biotechnology · last 5 Jun 20260 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
5 Jun 2026filed 9 Jun 2026STRO Sutro Biopharmaoption or derivative · BiotechnologySEC FORM 4 Code A—10,000 at $0.00filing
5 Jun 2026filed 9 Jun 2026STRO Sutro Biopharmaoption or derivative · BiotechnologySEC FORM 4 Code A—10,000 at $0.00filing
23 Dec 2025filed 29 Dec 2025STRO Sutro Biopharmaoption or derivative · BiotechnologySEC FORM 4 Code A—1,500 at $0.00filing
6 Jun 2025filed 10 Jun 2025STRO Sutro Biopharmaoption or derivative · BiotechnologySEC FORM 4 Code A—50,000 at $0.00filing
6 Jun 2024filed 10 Jun 2024STRO Sutro Biopharmaoption or derivative · BiotechnologySEC FORM 4 Code A—35,000 at $0.00filing
8 Jun 2023filed 12 Jun 2023STRO Sutro Biopharmaoption or derivative · BiotechnologySEC FORM 4 Code A—25,000 at $0.00filing
6 Jun 2022filed 8 Jun 2022STRO Sutro Biopharmaoption or derivative · BiotechnologySEC FORM 4 Code A—18,500 at $0.00filing
3 Jun 2021filed 7 Jun 2021STRO Sutro Biopharmaoption or derivative · BiotechnologySEC FORM 4 Code A—18,500 at $0.00filing
5 Jun 2020filed 8 Jun 2020STRO Sutro Biopharmaoption or derivative · BiotechnologySEC FORM 4 Code A—12,000 at $0.00filing
7 Jan 2020filed 8 Jan 2020STRO Sutro Biopharmaoption or derivative · BiotechnologySEC FORM 4 Code A—24,000 at $0.00filing
29 May 2014filed 2 Jun 2014diaDexusoption or derivativeSEC FORM 4 Code A—60,000 at $0.00filing
6 Aug 2013filed 8 Aug 2013diaDexusoption or derivativeSEC FORM 4 Code A—60,000 at $0.00filing
6 Aug 2013filed 8 Aug 2013diaDexusSEC FORM 4 Code A—6,500 at $0.00filing
20 Sep 2012filed 24 Sep 2012diaDexusoption or derivativeSEC FORM 4 Code A—60,000 at $0.00filing
10 Aug 2011filed 12 Aug 2011diaDexusoption or derivativeSEC FORM 4 Code A—170,000 at $0.00filing
29 Jul 2010filed 2 Aug 2010Vaxgenoption or derivativeSEC FORM 4 Code D—360,000 at $0.00filing
29 Jul 2010filed 2 Aug 2010Vaxgenoption or derivativeSEC FORM 4 Code D—60,000 at $0.00filing
29 Jul 2010filed 2 Aug 2010Vaxgenoption or derivativeSEC FORM 4 Code D—60,000 at $0.00filing
29 Jul 2010filed 2 Aug 2010Vaxgenoption or derivativeSEC FORM 4 Code D—60,000 at $0.00filing
29 Jul 2010filed 2 Aug 2010Vaxgenoption or derivativeSEC FORM 4 Code A—60,000 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed1

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.